1188 related articles for article (PubMed ID: 29357123)
1. Triglyceride Metabolism in the Liver.
Alves-Bezerra M; Cohen DE
Compr Physiol; 2017 Dec; 8(1):1-8. PubMed ID: 29357123
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease.
Kawano Y; Cohen DE
J Gastroenterol; 2013 Apr; 48(4):434-41. PubMed ID: 23397118
[TBL] [Abstract][Full Text] [Related]
3. Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation.
Cui CX; Deng JN; Yan L; Liu YY; Fan JY; Mu HN; Sun HY; Wang YH; Han JY
J Ethnopharmacol; 2017 Aug; 208():24-35. PubMed ID: 28648927
[TBL] [Abstract][Full Text] [Related]
4. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
Geisler CE; Renquist BJ
J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
[TBL] [Abstract][Full Text] [Related]
5. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).
Musso G; Gambino R; Cassader M
Prog Lipid Res; 2009 Jan; 48(1):1-26. PubMed ID: 18824034
[TBL] [Abstract][Full Text] [Related]
6. Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis.
Alves-Bezerra M; Li Y; Acuña M; Ivanova AA; Corey KE; Ortlund EA; Cohen DE
Hepatology; 2019 Aug; 70(2):496-510. PubMed ID: 30516845
[TBL] [Abstract][Full Text] [Related]
7. Metabolic-associated fatty liver disease and lipoprotein metabolism.
Heeren J; Scheja L
Mol Metab; 2021 Aug; 50():101238. PubMed ID: 33892169
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological intervention of liver triacylglycerol lipolysis: The good, the bad and the ugly.
Quiroga AD; Lehner R
Biochem Pharmacol; 2018 Sep; 155():233-241. PubMed ID: 30006193
[TBL] [Abstract][Full Text] [Related]
9. PNPLA2 influences secretion of triglyceride-rich lipoproteins by human hepatoma cells.
Taxiarchis A; Mahdessian H; Silveira A; Fisher RM; Van't Hooft FM
J Lipid Res; 2019 Jun; 60(6):1069-1077. PubMed ID: 30918066
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Investigation of High-Fat Diet-Induced Hepatic Lipid Dysfunctions.
Korach-André M
Methods Mol Biol; 2020; 2164():109-119. PubMed ID: 32607888
[TBL] [Abstract][Full Text] [Related]
11. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
12. Characterization of lipid metabolism in a novel immortalized human hepatocyte cell line.
Green CJ; Johnson D; Amin HD; Sivathondan P; Silva MA; Wang LM; Stevanato L; McNeil CA; Miljan EA; Sinden JD; Morten KJ; Hodson L
Am J Physiol Endocrinol Metab; 2015 Sep; 309(6):E511-22. PubMed ID: 26126685
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways.
Badmus OO; Hillhouse SA; Anderson CD; Hinds TD; Stec DE
Clin Sci (Lond); 2022 Sep; 136(18):1347-1366. PubMed ID: 36148775
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe Obesity.
Lytle KA; Bush NC; Triay JM; Kellogg TA; Kendrick ML; Swain JM; Gathaiya NW; Hames KC; Jensen MD
J Clin Endocrinol Metab; 2019 Dec; 104(12):6171-6181. PubMed ID: 31408176
[TBL] [Abstract][Full Text] [Related]
15. The link between Hepatic Vitamin A Metabolism and Nonalcoholic Fatty Liver Disease.
Chen G
Curr Drug Targets; 2015; 16(12):1281-92. PubMed ID: 25808650
[TBL] [Abstract][Full Text] [Related]
16. Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice.
Kubo H; Hoshi M; Matsumoto T; Irie M; Oura S; Tsutsumi H; Hata Y; Yamamoto Y; Saito K
Lipids Health Dis; 2017 Jun; 16(1):106. PubMed ID: 28578672
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis.
Koo SH
Clin Mol Hepatol; 2013 Sep; 19(3):210-5. PubMed ID: 24133660
[TBL] [Abstract][Full Text] [Related]
18. Zonation of hepatic fat accumulation: insights from mathematical modelling of nutrient gradients and fatty acid uptake.
Schleicher J; Dahmen U; Guthke R; Schuster S
J R Soc Interface; 2017 Aug; 14(133):. PubMed ID: 28835543
[TBL] [Abstract][Full Text] [Related]
19. Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease.
Xi Y; Li H
Biomed Pharmacother; 2020 Jan; 121():109609. PubMed ID: 31731192
[TBL] [Abstract][Full Text] [Related]
20. Mapping the triglyceride distribution in NAFLD human liver by MALDI imaging mass spectrometry reveals molecular differences in micro and macro steatosis.
Alamri H; Patterson NH; Yang E; Zoroquiain P; Lazaris A; Chaurand P; Metrakos P
Anal Bioanal Chem; 2019 Feb; 411(4):885-894. PubMed ID: 30515538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
